CAS 75172-81-5
:Migalastat hydrochloride
Description:
Migalastat hydrochloride is a pharmacological agent primarily used in the treatment of Fabry disease, a genetic disorder resulting from the deficiency of the enzyme alpha-galactosidase A. This compound acts as a chaperone, stabilizing the enzyme and facilitating its proper function, which helps to reduce the accumulation of certain lipids in the body. Chemically, Migalastat hydrochloride is characterized by its specific molecular structure, which includes a chiral center, contributing to its biological activity. It is typically administered orally and is known for its favorable pharmacokinetic profile, including good absorption and distribution in the body. The hydrochloride salt form enhances its solubility and stability. Migalastat hydrochloride has undergone extensive clinical trials, demonstrating its efficacy in reducing disease-related symptoms and improving quality of life for patients with Fabry disease. As with any medication, it is essential to consider potential side effects and contraindications, and it should be used under the guidance of a healthcare professional.
Formula:C6H13NO4·ClH
InChI:InChI=1S/C6H13NO4.ClH/c8-2-3-5(10)6(11)4(9)1-7-3;/h3-11H,1-2H2;1H/t3-,4+,5+,6-;/m1./s1
InChI key:InChIKey=ZJIHMALTJRDNQI-OLALXQGDSA-N
SMILES:C(O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)CN1.Cl
Synonyms:- 1-Deoxygalactonojirimycin hydrochloride
- 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3S,4R,5S)-
- 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride, (2R,3S,4R,5S)-
- 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride, [2R-(2α,3α,4α,5β)]-
- Galafold
- Migalastat HCl
- Migalastat hydrochloride
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 12 products.
3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride,[2R-(2a,3a,4a,5b)]-
CAS:Formula:C6H14ClNO4Purity:98%Color and Shape:SolidMolecular weight:199.63271-Deoxygalactonojirimycin, hydrochloride
CAS:<p>1-Deoxygalactonojirimycin, hydrochloride</p>Purity:98%Molecular weight:199.63g/molMigalastat-15N HCl
CAS:Formula:C6H1315NO4·HClColor and Shape:White To Off-White SolidMolecular weight:164.08 36.46Migalastat HCl
CAS:Formula:C6H13NO4·HClColor and Shape:White To Off-White SolidMolecular weight:163.17 36.46Migalastat hydrochloride
CAS:<p>Migalastat hydrochloride (GR181413A) 是一种可口服且具有有效和竞争性的 α-galactosidase A 抑制剂,可促进α-半乳糖苷酶A向溶酶体的运输,可用于研究法布里病。</p>Formula:C6H14ClNO4Purity:>99.99%Color and Shape:SolidMolecular weight:199.63(2R,3S,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol hydrochloride
CAS:(2R,3S,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol hydrochlorideFormula:C6H13NO4·ClHPurity:≥95%Color and Shape: off-white solidMolecular weight:199.63g/mol1-Deoxygalactonojirimycin hydrochoride
CAS:Formula:C6H13NO4·HClColor and Shape:White powder or crystalsMolecular weight:199.631-Deoxygalactonojirimycin Hydrochloride
CAS:<p>Applications Proven to be an extremely potent and selective a-D-galactosidase inhibitor.<br>References Paulsen, H., et al.: Chem. Ber., 113, 2601 (1980),<br></p>Formula:C6H13NO4·ClHColor and Shape:Off White SolidMolecular weight:199.631-Deoxygalactonojirimycin hydrochloride salt
CAS:<p>Specific and potent inhibitor of lysosomal α-galactosidase with IC50 in nanomolar range. It acts as pharmacological chaperone and assists folding of the wild type and mutant versions of the enzyme. It places itself in the instable active site and prevents the damage to the enzyme during the passage through Golgi apparatus, endoplasmatic reticulum and lysosome axis. The exposure to this compound leads to increased levels of functional α-galactosidase in models for lysosomal storage disorders and brings therapeutic benefits to patients with Fabry disease.</p>Formula:C6H13NO4·HClPurity:Min. 95 Area-%Color and Shape:White PowderMolecular weight:199.63 g/mol(2R,3S,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol hydrochloride
CAS:Purity:98+%Molecular weight:199.6300049








